share_log

10-K/A: Annual report (Amendment)

10-K/A: Annual report (Amendment)

10-K/A:年度报表(修正版)
美股SEC公告 ·  04/30 04:21

Moomoo AI 已提取核心信息

180 Life Sciences Corp. (180 Life Sciences) has filed an amended annual report for the fiscal year ended December 31, 2023. The report includes the dismissal of Marcum LLP as the independent registered public accounting firm and the engagement of M&K CPA’s, PLLC for the fiscal year 2024. The company has also entered into indemnification agreements with directors and officers, and has established a policy for the Audit Committee to review and approve any related party transactions. Legal actions involving former CEO Dr. Marlene Krauss and Tyche Capital LLC are ongoing, with the company vigorously defending its position. The company has also initiated legal action against Ronald Bauer and Samantha Bauer for misappropriated funds and stock shares. The Board has determined that new appointees Blair Jordan, Omar Jiminez, and Ryan Smith are independent directors. The report also details the compensation of directors and executive officers, including equity compensation plans and related fees for services rendered during the fiscal year.
180 Life Sciences Corp. (180 Life Sciences) has filed an amended annual report for the fiscal year ended December 31, 2023. The report includes the dismissal of Marcum LLP as the independent registered public accounting firm and the engagement of M&K CPA’s, PLLC for the fiscal year 2024. The company has also entered into indemnification agreements with directors and officers, and has established a policy for the Audit Committee to review and approve any related party transactions. Legal actions involving former CEO Dr. Marlene Krauss and Tyche Capital LLC are ongoing, with the company vigorously defending its position. The company has also initiated legal action against Ronald Bauer and Samantha Bauer for misappropriated funds and stock shares. The Board has determined that new appointees Blair Jordan, Omar Jiminez, and Ryan Smith are independent directors. The report also details the compensation of directors and executive officers, including equity compensation plans and related fees for services rendered during the fiscal year.
180 生命科学公司(180 Life Sciences)已提交了截至2023年12月31日的财年的修订年度报告。该报告包括解除Marcum LLP作为独立注册会计师事务所的职务,以及M&K CPA,PLLC在2024财年的聘用。该公司还与董事和高级管理人员签订了赔偿协议,并制定了一项政策,供审计委员会审查和批准任何关联方交易。涉及前首席执行官玛琳·克劳斯博士和泰驰资本有限责任公司的法律诉讼正在进行中,该公司正在大力捍卫自己的立场。该公司还以挪用资金和股票为由对罗纳德·鲍尔和萨曼莎·鲍尔提起法律诉讼。董事会已确定新任命的布莱尔·乔丹、奥马尔·吉米内斯和瑞安·史密斯为独立董事。该报告还详细介绍了董事和执行官的薪酬,包括股权薪酬计划和本财年提供服务的相关费用。
180 生命科学公司(180 Life Sciences)已提交了截至2023年12月31日的财年的修订年度报告。该报告包括解除Marcum LLP作为独立注册会计师事务所的职务,以及M&K CPA,PLLC在2024财年的聘用。该公司还与董事和高级管理人员签订了赔偿协议,并制定了一项政策,供审计委员会审查和批准任何关联方交易。涉及前首席执行官玛琳·克劳斯博士和泰驰资本有限责任公司的法律诉讼正在进行中,该公司正在大力捍卫自己的立场。该公司还以挪用资金和股票为由对罗纳德·鲍尔和萨曼莎·鲍尔提起法律诉讼。董事会已确定新任命的布莱尔·乔丹、奥马尔·吉米内斯和瑞安·史密斯为独立董事。该报告还详细介绍了董事和执行官的薪酬,包括股权薪酬计划和本财年提供服务的相关费用。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息